Impact of immunosenescence and inflammaging on the effects of immune checkpoint inhibitors
Author:
Funder
National Key Research and Development Program of China
Publisher
Elsevier BV
Reference106 articles.
1. Measuring population ageing: an analysis of the global burden of disease study 2017;Chang;Lancet Public Health,2019
2. Worldwide cancer statistics of adults over 75 years old in 2019: a systematic analysis of the global burden of disease study 2019;Xiang;BMC Publ Health,2022
3. Cancer immunotherapy: broadening the scope of targetable tumours;van den Bulk;Open Biol,2018
4. Immunosenescence and inflammaging in the aging process: age-related diseases or longevity?;Santoro;Ageing Res Rev,2021
5. Immune checkpoint inhibitors for the treatment of cancer: clinical impact and mechanisms of response and resistance;Bagchi;Annu Rev Pathol,2021
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Disseminate Cutaneous Vasculitis Associated with Durvalumab Treatment—Case Report, Mini-Review on Cutaneous Side Effects of Immune Checkpoint Inhibitor Therapies with Machine Learning Perspectives;Life;2024-08-25
2. Exploring the Complexity and Promise of Tumor Immunotherapy in Drug Development;International Journal of Molecular Sciences;2024-06-11
3. Cellular Senescence in Liver Cancer: How Dying Cells Become “Zombie” Enemies;Biomedicines;2023-12-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3